Combination therapy involving antibodies against Claudin 18.2 for treatment of cancer

• 收藏
• 分享

专利权人:

Ganymed Pharmaceuticals AG;TRON - Translationale Onkologie an der Universitatsmedizin der Johannes Gutenberg-Universitat Mainz Gemeinnutzige GmbH

发明人:

Sahin, Ugur,Tureci, Ozlem,Mitnacht-Kraus, Rita,Woll, Stefan,Jacobs, Stefan,Heinz, Cornelia

申请号：

AU2014221035

公开号：

AU2014221035A1

申请日:

2014.02.18

申请国别(地区):

AU

年份:

2015

代理人:

摘要：

The present invention provides a combination therapy for effectively treating and/or preventing diseases associated with cells expressing CLDN18.2, including cancer diseases such as pancreatic cancer and metastases thereof.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/